Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:P14/ARF-positive malignant pleural mesothelioma : ǂa ǂphenotype with distinct immune microenvironment
Avtorji:ID Pezzuto, Federica (Avtor)
ID Lunardi, Francesca (Avtor)
ID Vedovelli, Luca (Avtor)
ID Fortarezza, Francesco (Avtor)
ID Urso, Loredana (Avtor)
ID Grosso, Federica (Avtor)
ID Ceresoli, Giovanni Luca (Avtor)
ID Kern, Izidor, Klinika Golnik (Avtor)
ID Vlačić, Gregor, Klinika Golnik (Avtor)
ID Calabrese, Fiorella (Avtor)
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (13,14 MB)
MD5: 4A36A4ECD95DDC8C8E219734C590DB29
 
URL URL - Izvorni URL, za dostop obiščite https://www.frontiersin.org/articles/10.3389/fonc.2021.653497/full
 
Jezik:Angleški jezik
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:Logo UKPBAG - Univerzitetna klinika za pljučne bolezni in alergijo Golnik
Povzetek:Introduction: The CDKN2A gene plays a central role in the pathogenesis of malignant pleural mesothelioma (MPM). The gene encodes for two tumor suppressor proteins, p16/INK4A and p14/ARF, frequently lost in MPM tumors. The exact role of p14/ARF in MPM and overall its correlation with the immune microenvironment is unknown. We aimed to determine whether there is a relationship between p14/ARF expression, tumor morphological features, and the inflammatory tumor microenvironment. Methods: Diagnostic biopsies from 76 chemo-naive MPMs were evaluated. Pathological assessments of histotype, necrosis, inflammation, grading, and mitosis were performed. We evaluated p14/ARF, PD-L1 (tumor proportion score, TPS), and Ki-67 (percentage) by immunohistochemistry. Inflammatory cell components (CD3+, CD4+, CD8+ T lymphocytes; CD20+ B-lymphocytes; CD68+ and CD163+ macrophages) were quantified as percentages of positive cells, distinguishing between intratumoral and peritumoral areas. The expression of p14/ARF was associated with several clinical and pathological characteristics. A random forest-based machine-learning algorithm (Boruta) was implemented to identify which variables were associated with p14/ARF expression. Results: p14/ARF was evaluated in 68 patients who had a sufficient number of tumor cells. Strong positivity was detected in 14 patients (21%) (11 epithelioid and 3 biphasic MPMs). At univariate analysis, p14/ARF-positive epithelioid mesotheliomas showed higher nuclear grade (G3) (p = 0.023) and higher PD-L1 expression (≥50%) (p = 0.042). The percentages of CD4 and CD163 in peritumoral areas were respectively higher and lower in p14/ARF positive tumors but did not reach statistical significance with our sample size (both p = 0.066). The Boruta algorithm confirmed the predictive value of PD-L1 percentage for p14/ARF expression in all histotypes. Conclusions: p14/ARF-positive epithelioid mesotheliomas may mark a more aggressive pathological phenotype (higher nuclear grade and PD-L1 expression). Considering the results regarding the tumor immune microenvironment, p14/ARF-negative tumors seem to have an immune microenvironment less sensitive to immune checkpoint inhibitors, being associated with low PD-L1 and CD4 expression, and high CD163 percentage. The association between p14/ARF-positive MPMs and PD-L1 expression suggests a possible interaction of the two pathways. Confirmation of our preliminary results could be important for patient selection and recruitment in future clinical trials with anticancer immunotherapy.
Ključne besede:lung -- cytology -- pathology, neoplasms, malignant mesothelioma, malignant pleural mesothelioma, tumor microenvironment
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Kraj izida:Švica
Založnik:Frontiers
Leto izida:2022
Št. strani:str. 30-39
Številčenje:Vol. 11
PID:20.500.12556/DiRROS-15122 Novo okno
UDK:616
ISSN pri članku:2234-943X
DOI:10.3389/fonc.2021.653497 Novo okno
COBISS.SI-ID:103281667 Novo okno
Avtorske pravice:© 2021 Pezzuto, Lunardi, Vedovelli, Fortarezza, Urso, Grosso, Ceresoli, Kern, Vlacic, Faccioli, Schiavon, Gregori, Rea, Pasello and Calabrese
Opomba:Nasl. z nasl. zaslona; Soavtorja iz Slovenije: Izidor Kern, Gregor Vlačić; Opis vira z dne 4. 4. 2022;
Datum objave v DiRROS:30.05.2022
Število ogledov:794
Število prenosov:510
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Frontiers in oncology
Skrajšan naslov:Front. oncol.
Založnik:Frontiers Editorial Office
ISSN:2234-943X
COBISS.SI-ID:1601583 Novo okno

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:22.03.2022

Sekundarni jezik

Jezik:Ni določen
Ključne besede:pljuča --citologija -- patologija, novotvorbe, maligni mezoteliom, maligni plevralni mezoteliom, tumorsko mikrookolje


Nazaj